1. 5 Oral selective tyrosine kinase 2 (TYK2) inhibition with BMS-986165 in patients with systemic lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study (PAISLEY). (April 2019) Authors: Singhal, Shalabh; Shah, Vaishali; Crater, Chris; Hobar, Coby; Nguyen, Hoang; Throup, John; Banerjee, Subhashis; Merrill, Joan T Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarin. Issue 3 (October 2015) Authors: Farr, Amanda M.; Jing, Yonghua; Johnston, Stephen; Trocio, Jeffrey; Singhal, Shalabh; Bruno, Amanda; Graham, John Journal: Hospital practice Issue: Volume 43:Issue 3(2015) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial. Issue 2 (11th November 2022) Authors: Morand, Eric; Pike, Marilyn; Merrill, Joan T.; van Vollenhoven, Ronald; Werth, Victoria P.; Hobar, Coburn; Delev, Nikolay; Shah, Vaishali; Sharkey, Brian; Wegman, Thomas; Catlett, Ian; Banerjee, Subhashis; Singhal, Shalabh Journal: Arthritis & rheumatology Issue: Volume 75:Issue 2(2023) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis. Issue 6 (3rd March 2022) Authors: Mease, Philip J; Deodhar, Atul A; van der Heijde, Désirée; Behrens, Frank; Kivitz, Alan J; Neal, Jeffrey; Kim, Jonghyeon; Singhal, Shalabh; Nowak, Miroslawa; Banerjee, Subhashis Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 6(2022) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects. Issue 4 (19th February 2022) Authors: Chimalakonda, Anjaneya; Singhal, Shalabh; Darbenzio, Raymond; Dockens, Randy; Marchisin, David; Banerjee, Subhashis; Girgis, Ihab G.; Throup, John; He, Bing; Aras, Urvi; Murthy, Bindu Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 4(2022) Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population Pharmacokinetic Analysis of BMS‐986166, a Novel Selective Sphingosine‐1‐Phosphate‐1 Receptor Modulator, and Exposure‐Response Assessment of Lymphocyte Counts and Heart Rate in Healthy Participants. Issue 1 (8th October 2020) Authors: Bihorel, Sébastien; Singhal, Shalabh; Shevell, Diane; Sun, Huadong; Xie, Jenny; Basdeo, Shenita; Liu, Ang; Dutta, Santanu; Ludwig, Elizabeth; Huang, Hannah; Lin, Kuan‐ju; Fura, Aberra; Throup, John; Girgis, Ihab G. Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 1(2021) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The safety and pharmacokinetics of a novel, selective S1P1R modulator in healthy participants. (2nd April 2020) Authors: Singhal, Shalabh; Girgis, Ihab G.; Xie, Jenny; Dutta, Santanu; Shevell, Diane E.; Throup, John Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 4(2020) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0190 THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF BMS-986166, A NOVEL, SELECTIVE, PARTIAL AGONIST OF THE SPHINGOSINE-1-PHOSPHATE (S1P) SUBTYPE 1 RECEPTOR IN HEALTHY PARTICIPANTS. (June 2019) Authors: Singhal, Shalabh; Girgis, Ihab; Xie, Jenny; Dutta, Santanu; Shevell, Diane; Throup, John Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient setting. (4th March 2018) Authors: Henk, Henry J.; Cao, Feng; Tuell, Kenneth; Price, Kwanza; Singh, Prianka; Mardekian, Jack; Odell, Kevin; Patel, Chad; Tan, Wilson; Sands, George H.; Singhal, Shalabh; Trocio, Jeffrey; Vo, Lien Journal: Current medical research and opinion Issue: Volume 34:Number 3(2018) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗